How much funding has Ikena Oncology raised?

Ikena Oncology has raised $195.0M in total funding, most recently a Private Equity round.

Who are Ikena Oncology's investors?

Ikena Oncology's investors include Omega Funds, OrbiMed, Atlas Venture, Deep Track Capital, BVF Partners, Foresite Capital.

When was Ikena Oncology founded?

Ikena Oncology was founded in 2016.

Where is Ikena Oncology headquartered?

Ikena Oncology is headquartered in Boston, Massachusetts, United States.

What industry is Ikena Oncology in?

Ikena Oncology operates in Biotech.

How many employees does Ikena Oncology have?

Ikena Oncology has 11-50 employees.

Ikena Oncology

IPO

Redefining targeted oncology therapies

Public · Boston, United States · Founded 2016 · $195.0M raised

Biotech

Headquarters: Boston, Massachusetts
Employees: 11–50
Founded: 2016
Business Model: B2B
Website: ikenaoncology.com

Total Funding: $195.0M
Last Round: $75.0M Private EquityJul 2025
Rounds: 3
Type: Public

About

Ikena Oncology was a clinical-stage oncology biotech founded in 2016 in Cambridge/Boston, MA, formerly Kyn Therapeutics. Merged with ImageneBio July 2025.

Summary

Ikena Oncology is a Biotech company based in Boston, United States, founded in 2016. It has raised $195.0M in total across 3 rounds, most recently a $75.0M Private Equity round in Jul 2025. Investors include Omega Funds, OrbiMed and Atlas Venture.

LinkedIn X (Twitter)